|
140 |
EU Reaches Landmark on Reform of Pharmaceutical Legislation
|
관리자 |
2026-01-05 |
936 |
|
139 |
Root Cause Analysis and CAPA - Why FDA Keeps Calling Them Out
|
관리자 |
2025-11-28 |
801 |
|
138 |
Worst Case Selection in Cleaning Validation
|
관리자 |
2025-11-28 |
1,061 |
|
137 |
Advances in Digitalization and Automation of Aseptic Processing
|
관리자 |
2025-11-28 |
721 |
|
136 |
What is the Difference between Bracketing and Matrixing?
|
관리자 |
2025-11-04 |
1,327 |
|
135 |
Why Airflow Visualization Studies Matters in Laminar Flow Cabinets: Smoke Test Insights
|
관리자 |
2025-11-04 |
942 |
|
134 |
Thermal Mapping in Freeze-Drying: Ensuring Uniformity and GMP Compliance
|
관리자 |
2025-11-04 |
987 |
|
133 |
Operating And Maintaining Pharmaceutical Gas Distribution Systems
|
관리자 |
2025-09-30 |
1,257 |
|
132 |
Fermentation 101 – Bioprocess Development, Optimization & Scale-up
|
관리자 |
2025-09-30 |
1,022 |
|
131 |
Joint stakeholders consultation on the revision of Chapter 4 on Documentation, Annex 11 on Computerised Systems and on the new Annex 22 on Artificial Intelligence of the PIC/S and EU GMP Guides
|
관리자 |
2025-09-30 |
1,148 |
